HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...

Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls. HealthDay News — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent ...

Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic conditions.

Although no total cost is listed, labor alone is expected to cost at least $20 million and digital ads could cost tens of millions ...

The recall includes 7234 cases of juice, each with 24 bottles. The affected bottles have a "best by" date of December 5, 2026.

INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

HealthDay News — An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension ...

Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy.

At Sensient Technologies, one of the world’s largest dyemakers, scientists are working hard to find natural alternatives.